REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lohmann & Rauscher, S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lohmann & Rauscher, S.R.O. Profile Updated: February 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lohmann & Rauscher, S.R.O. is an enterprise in Czech Republic, with the main office in Slavkov u Brna. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on October 17, 1991. It currently has a total number of 500 - 999 (2026) employees. The company’s latest financial report indicates a net sales revenue increase of 10.37% in 2024. Its’ total assets recorded a growth of 6.07%. The enterprise’s net profit margin increased by 0.83% in 2024.

Headquarters
Bucovicka 256
Slavkov u Brna; Jihomoravsky; Postal Code: 68401

Contact Details: Purchase the Lohmann & Rauscher, S.R.O. report to view the information.

Website: https://www.lohmann-rauscher.com/cz-cs/

Basic Information
Total Employees:
Purchase the Lohmann & Rauscher, S.R.O. report to view the information.
Registered Capital:
Purchase the Lohmann & Rauscher, S.R.O. report to view the information.
Financial Auditors:
Purchase the Lohmann & Rauscher, S.R.O. report to view the information.
Incorporation Date:
October 17, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Lohmann & Rauscher, s.r.o. odstepny zavod
100%
Company Performance
Financial values in the chart are available after Lohmann & Rauscher, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
10.37%▲
Total Operating Revenue
10.14%▲
Operating Profit
24.74%▲
EBITDA
16.94%▲
Net Profit/Loss for the Period
26.16%▲
Total Assets
6.07%▲
Total Equity
9.5%▲
Operating Profit Margin
0.84%▲
Net Profit Margin
0.83%▲
Return on Equity (ROE)
1.75%▲
Quick Ratio
0.57%▲
Cash Ratio
0.08%▲

Similar companies

Zentiva, K.S.
 
Novartis S.R.O.
Teva Czech Industries S.R.O.
 
Novavax Cz A.S.
Hartmann - Rico A.S.
 
Glenmark Pharmaceuticals S.R.O.
Roche S.R.O.
 
Molnlycke Health Care Procedurepak S.R.O.
Teva Pharmaceuticals Cr, S.R.O.
 
Pro.Med.Cs Praha A.S.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo